乳腺癌肝转移介入治疗疗效分析

Efficacy analysis of intervention for metastatic breast cancer

目的探讨介入治疗对乳腺癌肝转移的治疗效果,并对其在乳腺癌肝转移综合治疗中的价值进行评价。方法对我院2006年1月～2010年12月就诊的46例乳腺癌肝转移患者设为观察组进行介入治疗,药物选择为顺铂、丝裂霉素、阿霉素、5-氟尿嘧啶等,其中38例进行超液化碘油栓塞,与31例采用化学治疗的患者(对照组)进行对比分析。结果本组46例乳腺癌肝转移患者经介入治疗后,完全缓解9例,部分缓解19例,进展7例,无变化11例。结论乳腺癌肝转移的介入治疗疗效显著,毒副作用小,应作为乳腺癌肝转移综合治疗中的主要治疗手段。

Objective To investigate the intervention on the treatment of metastatic breast cancer, and its comprehensive treatment of metastatic breast cancer in the value of the evaluation. Methods 46 cases of metastatic breast cancer patients from January 2006 to December 2010 recieved interventional therapy, which administratecd cisplatin, mitomycin, doxorubicin, or 5-fluorouracil, etc. and 38 cases received li- piodol embolism. Results 46 patients with metastatic breast cancer went through interventional therapy, complete remission in 9 cases, partial remission in 19 cases, progress in 7 cases, no change in 11 cases. Conclusion Interventional treatment should be a comprehensive treatment of metastatic breast cancer in the primary treatment for liver metastasis of breast cancer due to significant effect and lower toxicity.